99% Savings - Buy Just @1 Rs X
Glycigon M Tablet SR is a commercial drug that is prescribed in the form of Tablet. Diabetes are some of its major therapeutic uses. Glycigon M Tablet SR also has some secondary and off-label uses. These are listed below.
The optimal dosage of Glycigon M Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Glycigon M Tablet SR also has some side effects, the most common being Nausea or vomiting, Bradycardia, Constipation. Besides the aforementioned side effects, there are other adverse effects of Glycigon M Tablet SR as well, which are listed below. Normally, these side effects of Glycigon M Tablet SR are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Glycigon M Tablet SR's effect is Moderate during pregnancy and Safe for lactating mothers. Warnings related to Glycigon M Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Glycigon M Tablet SR contraindications section.
Drug interactions for Glycigon M Tablet SR have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Glycigon M Tablet SR is safe while driving, and is addiction.
Glycigon M Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Glycigon M Tablet SR safe for pregnant women?
Pregnant women may experience moderate side effects from Glycigon M. It is best to stop taking Glycigon M immediately and inform your doctor if you notice any discomfort.
Is the use of Glycigon M Tablet SR safe during breastfeeding?
Glycigon M does not show any harmful effects in lactating women.
What is the effect of Glycigon M Tablet SR on the Kidneys?
Kidney can be affected by Glycigon M. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glycigon M Tablet SR on the Liver?
Glycigon M may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glycigon M Tablet SR on the Heart?
Glycigon M may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Glycigon M Tablet SR unless your doctor advises you to do so -
Is this Glycigon M Tablet SR habit forming or addictive?
No, there is no any evidence that Glycigon M Tablet SR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Glycigon M Tablet SR since it will not make you feel sleepy.
Is it safe?
Yes, Glycigon M Tablet SR is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Glycigon M Tablet SR for mental disorders.
Interaction between Food and Glycigon M Tablet SR
It is safe to take Glycigon M Tablet SR with food.
Interaction between Alcohol and Glycigon M Tablet SR
Taking Glycigon M Tablet SR with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826